As we move on to our next case, we're going to see if changing the patient’s story will change the diagnostic direction for another interstitial lung disease, scleroderma.
You are now leaving a Boehringer Ingelheim Pharmaceuticals, Inc. site. Boehringer Ingelheim Pharmaceuticals, Inc. has not reviewed the contents of all pages and sites that may be linked to this site. Boehringer Ingelheim
Pharmaceuticals, Inc. is not responsible and disclaims any liability for the content of any other page or site or for any viruses or similar harmful programs that may be present on such pages or sites. Linking to any other
page or site is at your own risk.
